Printer Friendly 14,557,847 articles and books

Periodicals Literature Keyword Title Author Topic

Member login User name    Password    Remember me Join us Forgot password?

Submit articles free

Browse Vaccines topic

Product development subtopic

Articles 1-100 out of 100 article(s) Title Author Type Date Words South Africa : Synexus Leads Way In South Africa With Vital Paediatric Vaccines Trial. Nov 26, 2009 384 Synexus Leads the Way in South Africa with Vital Paediatric Vaccines Trial. Nov 25, 2009 368 Antigenics Provides Details On GlaxoSmithKline's Pivotal Malaria Vaccine Trial With QS-21 Adjuvant. Nov 4, 2009 611 Africa trial for malaria vaccine. Nov 4, 2009 478 Africa trial for malaria vaccine. Nov 3, 2009 478 Celldex Therapeutics Presents Positive Clinical Data from Phase 1 Studies of Antibody-Based Cancer Vaccine Candidate, CDX-1307. Oct 29, 2009 941 Trials to test H1N1 vaccine efficacy in HIV-infected pregnant women underway. Oct 21, 2009 418 Trials to test H1N1 vaccine efficacy in HIV-infected pregnant women underway. Oct 18, 2009 418 United States : Vaccine trial showing positive results for Vical. Oct 12, 2009 136 HAWAII BIOTECH BEGINS PHASE 1 CLINICAL TRIAL FOR DENGUE VACCINE. Oct 1, 2009 502 Dynavax Initiates Phase 3 Registration Trial in Chronic Kidney Disease Patients for HEPLISAVTM Hepatitis B Vaccine. Sep 29, 2009 743 International Medica Foundation Starts Phase II Clinical Trial for Rotavirus Vaccine. Sep 28, 2009 691 IAVI Statement on Results of Phase III ALVAC-AIDSVAX Trial in Thailand. Sep 24, 2009 313 CSL Biotherapies Announces Start of U.S. H1N1 Vaccine Clinical Trials. Clinical report Aug 24, 2009 969 United States : Sinovac Biotech announces positive results from clinical trial of H1N1 vaccine. Aug 19, 2009 432 NanoBio to Present Preclinical Data on its Novel, Nanoemulsion-based Vaccine Adjuvant Platform at the Immunotherapeutics & Vaccine Summit. Aug 17, 2009 312 First inhalant powder measles vaccine to undergo clinical trials in India next year. Aug 17, 2009 495 Radiant Research, Inc. Prepares for Upcoming H1N1 Vaccine Trials. Jun 26, 2009 304 Genetic analysis of swine flu virus finds new mixture of diverse parts: H1N1 may be amenable to future vaccine development. Saey, Tina Hesman Jun 20, 2009 616 Antigenics' QS-21 Adjuvant Enters Pivotal Phase 3 Clinical Trial of GlaxoSmithKline's Malaria Vaccine. Jun 17, 2009 633 Positive, Clinically Significant Phase III Results for Personalized Anti-Cancer Vaccine, BiovaxID[R], Presented at ASCO Plenary Session. Clinical report May 31, 2009 1721 Personalized Anti-Cancer Vaccine Pivotal Phase III Results to be Presented at ASCO Plenary Session. May 20, 2009 1011 Malaria vaccine being developed in Delhi. Apr 24, 2009 454 Cytomegalovirus vaccine. Seppa, Nathan Brief article Apr 11, 2009 57 United States: Hawaii Biotech Reports Phase 1 Results for West Nile Virus Vaccine. Financial report Feb 26, 2009 382 Hawaii Biotech Reports Phase 1 Results for West Nile Virus Vaccine. Financial report Feb 25, 2009 486 United States : Celldex signs licensing and development agreement with Vaccine Technologies. Jan 23, 2009 298 Hawaii Biotech Completes Dosing of Phase 1 Trial for West Nile Virus Vaccine. Dec 15, 2008 386 Early trials success for malaria vaccine; Study: Illness cut by more than half; Gates Foundation helped pay for research. Dec 9, 2008 438 Final Data From Phase 1 Investigator-Sponsored Trial of Oncophage[R] Cancer Vaccine in Glioma Presented at the Society for Neuro-Oncology's Annual Meeting. Nov 24, 2008 904 United States : DFID announces call for applications for new product development partnerships for drugs and vaccines. Oct 9, 2008 141 NOVAVAX GETS GOOD RESULTS FROM PHASE I/IIA VACCINE STUDY. Report Oct 1, 2008 930 AVANTOGEN'S HAWAII BIOTECH GETS WALTER REED TRIAL SUPPORT. Oct 1, 2008 631 Top-Line Data from Opexa's Phase IIb Tovaxin(R) Study to be Presented at World Congress on Treatment and Research in Multiple Sclerosis. Sep 11, 2008 994 Death mystery of 14 children in trials of pneumonia drug. Aug 16, 2008 445 Death mystery of 14 children and trials of pneumonia drug. Aug 16, 2008 446 Encorium Group Signs $3.5 Million of New Contracts for Vaccines Clinical Trials. Aug 13, 2008 1053 Dynavax and Merck & Co., Inc. Announce Phase 3 Trial with Investigational Hepatitis B Vaccine (HEPLISAV(TM)) Met its Primary Endpoint. Aug 5, 2008 976 Denmark: Angel Biotechnology gets milestone payment for diarrhoea vaccine development. Jul 18, 2008 77 Biovest Reports Results for Patients Treated with Anti-Cancer Vaccine: BiovaxID(R) Demonstrates Clinically and Statistically Significant Improvement of Disease-Free Survival in Non-Hodgkin's Lymphoma in Pivotal Phase 3 Clinical Trial. Financial report Jul 17, 2008 1194 VGX Pharmaceuticals receives FDA approval of IND for novel DNA vaccine for cervical cancer therapy. Jul 1, 2008 277 Hawaii Biotech Initiates Phase 1 Clinical Trial for West Nile Vaccine. Jun 23, 2008 325 invivodata Captures Primary Efficacy Data in Largest Controlled Allergy Vaccine Trial. Jun 17, 2008 577 Emergent BioSolutions Initiates U.S. Phase II Trial of Oral Typhoid Vaccine Candidate. Jun 5, 2008 1325 NIH Initiates Phase 1 Safety Study of AVANT's Oral Combined Enterotoxigenic E. coli-Cholera Vaccine. Jun 4, 2008 1361 India: Bharat Biotech Announces Successful Completion of its Phase I/II Clinical Trial for 116E Rotavirus Vaccine. May 30, 2008 415 Dynavax and Merck & Co., Inc. Update Status of Clinical Hold of Investigational Vaccine HEPLISAV(TM). Apr 17, 2008 790 Significant Tumor-Specific Immune Response Observed in AVANT's Phase 2 Trial Evaluating CDX-110 with Temozolomide for Treatment of Glioblastoma Multiforme. Apr 15, 2008 1504 Prostate Cancer DNA Vaccine Results in Higher T-Cell Response When Delivered via Inovio Biomedical's Electroporation Delivery System. Clinical report Apr 4, 2008 1717 AVANT's Single-Dose Oral Ty800 Vaccine Meets Primary Endpoints in Phase 2 Study. Apr 1, 2008 1487 Encorium Group, Inc. Announces $1.6 Million Contract for a Phase 2 Trial of an Innovative Immunotherapeutic Vaccine for the Treatment of Hypertension. Mar 31, 2008 1049 Dynavax and Merck & Co., Inc. Report Clinical Hold of Investigational Vaccine HEPLISAV. Mar 17, 2008 1040 Inovio Biomedical to Present New Data from Melanoma Immunotherapy Clinical Trial at DNA Vaccines Forum 2008. Mar 4, 2008 1013 Novartis first to focus on innovative vaccines. Mar 1, 2008 663 InvestBio Portfolio Company Presents Phase I/II Trial Results of Vaccine for Leukemia at American Society of Hematology Annual Meeting. Feb 29, 2008 475 Emergent BioSolutions Announces That the Final Phase II Clinical Study Results for Typhoid Vaccine Reaffirms Clinical Endpoints Met; Immune Response Seen in 97% of Treated Subjects. Medical condition overview Jan 8, 2008 1289 Billion dollar injection. Brief article Jan 1, 2008 271 Inovio Biomedical Receives Additional Milestone Payment from Merck Relating to Electroporation Delivery System for DNA Vaccines. Dec 12, 2007 870 FDA Approves Phase I Clinical Trial for SKCC Breast Cancer Vaccine. Dec 10, 2007 530 Inovio Biomedical Partner Tripep Treats First Subject in Phase I/II Study of Novel Hepatitis C DNA Vaccine. Nov 27, 2007 1468 Praxis' Campaign Saves 12 Weeks Off Enrollment Goal for Women's Health Vaccine Study. Oct 30, 2007 277 Biovest Announces Strategy for Seeking Early Approval of Its Anti-Cancer Vaccine for Non-Hodgkins Lymphoma. Oct 16, 2007 1212 First Patient Registered in Investigator-Sponsored Phase 2 Trial of Antigenics' Oncophage Cancer Vaccine in Glioma. Oct 10, 2007 853 Advaxis, Inc. Phase I/II Results of Lovaxin C in Cervical Cancer Study Released. Oct 9, 2007 828 Opexa Therapeutics Gives Update on Phase IIb Trial of Tovaxin(R) for Treatment of Multiple Sclerosis. Clinical report Sep 11, 2007 788 Meridian Bioscience, Inc. Announces the Commencement of Phase I/II Clinical Trials of Parvovirus B19 Vaccine. Aug 28, 2007 792 Inovio Biomedical Partner Tripep Receives Approval to Initiate Phase I/II Study of Novel Vaccine for Hepatitis C Virus. Aug 16, 2007 1358 Application for Rotarix(R) by AVANT's Partner, GlaxoSmithKline, is Accepted for Review by the FDA. Aug 14, 2007 1127 AVANT Commences Phase 2 Clinical Trial of Its Single Dose, Oral Typhoid Fever Vaccine. Clinical report Jul 30, 2007 1061 Hemispherx Biopharma Initiates Phase IIb Trial in Australia for Ampligen as Vaccine Adjuvant for Seasonal Influenza. Jun 26, 2007 828 Vakzine Projekt Management Reports Positive Clinical Trial Results With Their Therapeutic Prostate Cancer Vaccine VPM4001. Clinical report Jun 1, 2007 421 More with less. Weeks, Katie Brief article Apr 16, 2007 166 Human infectious diseases remain focus of vicars vaccine research: biotech boasts plentiful pipeline, two drugs in late phase trials. Weeks, Katie Apr 2, 2007 897 GenVec Signs Cooperative Research and Development Agreement (CRADA) with the National Institute of Allergy and Infectious Diseases (NIAID) to Develop RSV Vaccines. Mar 20, 2007 612 "Breakthrough" vaccine for women. Wagner, Don Brief article Feb 1, 2007 74 Introgen's INGN 225 Molecular Cancer Vaccine Demonstrates Promising Results in Phase 2 Trial. Jan 29, 2007 638 National Institutes of Health to Sponsor Clinical Trial for Emergent BioSolutions' Group B Streptococcus Vaccine Candidate. Dec 21, 2006 1135 Positive Clinical Trial Results Using GenVec's Adenovirus Vector Technology to Deliver a Candidate HIV-1 Vaccine Reported in the Journal of Infectious Diseases. Dec 15, 2006 601 HER2/neu Vaccine Results Spurs Phase III Planning by Apthera, Inc. Dec 14, 2006 412 Positive Phase II Clinical Trial Results with HER2/neu Vaccine. Dec 14, 2006 1013 Merck & Co., Inc. and Idera Pharmaceuticals Sign Collaboration Agreement Incorporating Idera's Toll-like Receptor Agonists in Merck's Vaccine Programs. Dec 11, 2006 1111 AVAX Technologies Announces Special Protocol Assessment Agreement with FDA for a Phase III Clinical Trial of M-Vax in Metastatic Melanoma. Oct 12, 2006 1389 Advaxis Meets with FDA Regarding Phase II of Lovaxin C. Sep 25, 2006 587 Shingles shot's value is uncertain. Brief article Sep 23, 2006 293 MolecularMD Enters into Agreement with Breakthrough Therapeutics to Support Phase II Clinical Trial of ABLVAX(TM). Aug 30, 2006 476 DOR BioPharma Announces Successful Completion of cGMP Production Milestone for RiVax(TM). Jul 6, 2006 1177 FDA Grants Biovest International Fast Track Status for BiovaxID(TM); Personalized Vaccine for Follicular Non-Hodgkin's Lymphoma Receives Fast Track Status from FDA. May 11, 2006 906 FDA Grants Accentia Biopharmaceuticals, Inc.'s Majority-Owned Subsidiary Fast Track Status for BiovaxID(TM); Personalized Vaccine for Follicular Non-Hodgkin's Lymphoma Receives Fast Track Status from FDA. May 11, 2006 916 Protecting people from a terrifying toxin: vaccine stimulates immune response against ricin. Harder, B. Feb 4, 2006 441 Rotavirus vaccines pass big safety tests. Brief Article Feb 4, 2006 174 DOR BioPharma Announces Positive Phase I Results of RiVax(TM), its Vaccine Against Ricin Toxin; Vaccine is Immunogenic and Well Tolerated. Jan 30, 2006 1537 Lancell, LLC Receives CCAT(SM) Award. Dec 28, 2005 505 GlycoFi and Merck & Co., Inc. Enter into Broad Strategic Alliance for Research and Development; Multi-Year Collaboration to Develop Merck Products on GlycoFi Platform. Dec 12, 2005 291 SARS vaccine development. Liu, Shuwen Jul 1, 2005 3816 A shot against prostate cancer? Brief Article Mar 29, 2005 70 Assessing the Role of IPRs to foster R&D: the case of vaccines and drugs for neglected diseases. Szogs, Astrid Report Oct 1, 2004 6009 Injecting tyranny: anti-drug "vaccines". Sullum, Jacob Oct 1, 2004 374 Juvaris Biotherapeutics announces licensing agreement for therapeutic vaccine platform. May 1, 2004 565 SARS vaccine tests well in mouse model. Brief Article Apr 10, 2004 223 West Nile virus update. Brief Article Oct 1, 2003 231

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles